EGFR and ovarian neoplasm: Milane et al. [163] demonstrated that epidermal growth factor receptor (EGFR)-targeted polymeric nanoparticles loaded with ionidamine and paclitaxel displayed antitumor activity through down regulation of MDR proteins in human breast and ovarian tumor cells.